Guardion Health Sciences’ (NASDAQ:GHSI) quiet period is set to end on Wednesday, May 15th. Guardion Health Sciences had issued 1,250,000 shares in its initial public offering on April 5th. The total size of the offering was $5,000,000 based on an initial share price of $4.00. During the company’s quiet period, insiders and underwriters involved in the IPO are restricted from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Following the expiration of the company’s quiet period, the brokerages that served as underwriters will likely initiate research coverage on the company.
GHSI opened at $1.86 on Wednesday. Guardion Health Sciences has a 52-week low of $1.36 and a 52-week high of $4.00.
About Guardion Health Sciences
Guardion Health Sciences, Inc, a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. It operates in two segments, Medical Foods and Vision Testing Diagnostics. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.
Featured Article: Marijuana Stocks Investing Considerations
Receive News & Ratings for Guardion Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardion Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.